Princeton, NJ 12/1/15—Certara has purchased XenologiQ, a quantitative systems pharmacology (QSP) consultancy for an undisclosed amount. According to Certara, “QSP is an emerging biosimulation discipline that combines computational modeling and experimental methods to examine the mechanistic relationships between a drug, the biological system, and the disease process.” XenologiQ will become part of Certara’s Simcyp division, […]
Skokie, IL 12/1/15—Integrated DNA Technologies (IDT) has agreed to acquire AITbiotech’s oligonucleotide synthesis business, which is based in Singapore. Financial details were not disclosed. IDT stated that the acquisition will expand its Southeast Asian customer base.
Darmstadt, Germany 12/10/15—At its 2015 Capital Market Day, Merck KGaA provided details about its merger with Sigma-Aldrich (see IBO 11/30/15) and how it plans to realize the €260 million ($286 million = €0.91 = $1) in synergies by 2018. Merck Life Science now consists of Research Solutions, representing 35% of revenues; Process Solutions, which make […]
St. Louis, MO 12/9/15—Manufacturing and distribution firm Harbour Group has acquired SP Industries, a provider of scientific equipment, biologic manufacturing solutions and labware, for an undisclosed amount. “SP’s brand strength, breadth of product and in-house manufacturing capabilities fit very well with our experience in the manufactured products sector,” said Harbour Chairman and CEO Jeff Fox. […]
London, UK 12/8/15; London, UK 12/8/15—Life sciences measurement and testing company LGC has been sold by private equity firm Bridgepoint to investment company KKR for an undisclosed amount. UK-based LGC provides life science testing products and services for a variety of markets, including pharmaceutical, agricultural biotechnology, food, environment, government and academia. LGC posted fiscal 2015 […]
Published this month by the European Commission (EC), the 2015 EU Industrial R&D Scoreboard tracked the spending of 2,500 publicly held companies in 44 countries across 41 industries that are the world’s largest R&D spenders. Together, these companies represented an estimated 90% of global business R&D and 55% of total R&D spending in fiscal 2014 […]
A subsegment of the qPCR market, nanoliter qPCR technologies have expanded qPCR capabilities and applications, enabling thousands of assays to be performed simultaneously with smaller sample amounts, resulting in lower reagent costs, higher throughput and more data points. Nanoliter PCR formats were introduced in the late 2000s and initially aimed at the largest application segments […]
According to a new report by Deloitte, R&D return on investments generated from the pharmaceutical industry’s annual investment in new product innovation have continued to decline. The annual projected R&D returns were 10.1% in 2010; in 2015, the returns were down to 4.2%. Since 2010, Deloitte’s original cohort of 12 companies has launched 186 products […]
The NSF has released preliminary figures for the US federal government’s budget authority for fiscal 2015. Total R&D and R&D-plant budget authority grew 0.7% to $137.2 billion in current dollars, down from 2.8% growth in fiscal 2014. Adjusted for inflation, both years’ levels are nearly flat with fiscal 2010. Nondefense R&D and R&D-plant budget authority […]
X-ray diffraction (XRD) is a nondestructive technique designed to probe the properties of crystalline materials. More commonly associated with the analysis of powders and single crystals for compounds and proteins of pharmaceutical interest, the technique is also used for residual-stress measurements in metals, advanced ceramics and other rigid samples. Residual stress is a measurement of […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
